Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 infusion for blood glucose control during enteral feeding in critically ill ventilated adults
ACTRN12609000093280Phase 2Completed
- Sponsor
- Adam Deane
- Start
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of Glucagon-like peptide 1 in hyperglycemia (2 arms), sponsored by Adam Deane. Primary endpoint: Blood glucose during small intestinal feeding. Started Jul 2008; status: completed.
02
Drugs
Glucagon-like peptide 1
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on ACTRN12609000093280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000093280.